A. Buzdar
M.D. Anderson Cancer Center
University of Texas
Houston
Department of Breast Medical Oncology 77030
USA
Name/email consistency: high
- Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. Buzdar, A., Jonat, W., Howell, A., Jones, S.E., Blomqvist, C., Vogel, C.L., Eiermann, W., Wolter, J.M., Azab, M., Webster, A., Plourde, P.V. J. Clin. Oncol. (1996)